BioSpace News Archive

Drug Development

Pfizer Starts Study of mRNA-Based Next Generation Flu Vaccine Program

Pfizer Inc. (NYSE: PFE) announced today that the first participants have been dosed in a Phase 1 clinical trial to evaluate the safety, tolerability, and immunogenicity of a single dose quadrivalent mRNA vaccine against influenza in healthy adults.

September 27, 2021
·
8 min read
FDA

ANP Technologies, Inc. Receives FDA EUA Authorization for its NIDS® COVID-19 Antigen Rapid Test Kit

ANP Technologies, Inc. Receives FDA EUA Authorization for its NIDS ® COVID-19 Antigen Rapid Test Kit

September 27, 2021
·
2 min read
Biotech Bay

Gilead Marks Fifth Approval for Trodelvy® in Metastatic Triple-Negative Breast Cancer Under Project Orbis Initiative with Health Canada Authorization

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Health Canada has approved Trodelvy® (sacituzumab govitecan-hziy) for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who have received two or more prior therapies, at least one of them for metastatic disease.

September 27, 2021
·
14 min read
Business

IDEX Corporation to Webcast Third Quarter 2021 Earnings Call

IDEX CORPORATION (NYSE:IEX) announced today that it has scheduled the broadcast of the company’s third quarter earnings conference call over the Internet on Wednesday, October 27, 2021 at 9:30 a.m. CT.

September 27, 2021
·
2 min read
Business

ASC Therapeutics Appoints Gene and Cell Therapy Manufacturing Veteran Gary Potter to lead Global Operations

ASC Therapeutics announces the appointment of Gary Potter as Senior Vice President, Global Operations.

September 27, 2021
·
5 min read